Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Journal of Urban Law
|
February 1, 1973
Constitutional law--New Jersey abortion statute unconstitutionally vague on its face
A G McIntyre
European Journal of Pediatrics
|
February 9, 2000
Procalcitonin may help differentiate disseminated herpes simplex viral infection from bacterial sepsis in neonates
M Hatherill, K Sykes, A G McIntyre, et al.
Intensive Care Medicine
|
May 24, 2000
Early hyperlactataemia in critically ill children
M Hatherill, A G McIntyre, M Wattie, et al.
The British Journal of Radiology
|
March 7, 2012
"Black bone" MRI: a partial flip angle technique for radiation reduction in craniofacial imaging
K A Eley, A G McIntyre, S R Watt-Smith, et al.
Sleep & Breathing = Schlaf & Atmung
|
December 4, 2017
Relationships between MRI fat distributions and sleep apnea and obesity hypoventilation syndrome in very obese patients
C D Turnbull, S H Wang, A R Manuel, et al.
JTO Clinical and Research Reports
|
March 23, 2026
First-Line Cemiplimab for Locally Advanced NSCLC: Updated Subgroup Analyses From the EMPOWER-Lung 1 and EMPOWER-Lung 3 Trials
Ewa Kalinka, Igor Bondarenko, Miranda Gogishvili, et al.
Cancer
|
May 5, 2025
Cemiplimab monotherapy as first-line treatment of patients with brain metastases from advanced non-small cell lung cancer with programmed cell death-ligand 1 ≥50
Saadettin Kilickap, Mustafa Özgüroğlu, Ahmet Sezer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 15, 2026
Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-year Results From Phase 3 EMPOWER-Lung 3 Part 2 Trial
Ana Baramidze, Tamta Makharadze, Miranda Gogishvili, et al.
Cancer Treatment and Research Communications
|
July 23, 2025
Peripheral blood cells as prognostic markers in patients with advanced non-small cell lung cancer treated with cemiplimab as monotherapy or in combination with chemotherapy
Rolando J Acosta, Debra A G McIntyre, Joseph C Murray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 20, 2024
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Journal of Urban Law
|
February 1, 1973
Constitutional law--New Jersey abortion statute unconstitutionally vague on its face
A G McIntyre
European Journal of Pediatrics
|
February 9, 2000
Procalcitonin may help differentiate disseminated herpes simplex viral infection from bacterial sepsis in neonates
M Hatherill, K Sykes, A G McIntyre, et al.
Intensive Care Medicine
|
May 24, 2000
Early hyperlactataemia in critically ill children
M Hatherill, A G McIntyre, M Wattie, et al.
The British Journal of Radiology
|
March 7, 2012
"Black bone" MRI: a partial flip angle technique for radiation reduction in craniofacial imaging
K A Eley, A G McIntyre, S R Watt-Smith, et al.
Sleep & Breathing = Schlaf & Atmung
|
December 4, 2017
Relationships between MRI fat distributions and sleep apnea and obesity hypoventilation syndrome in very obese patients
C D Turnbull, S H Wang, A R Manuel, et al.
JTO Clinical and Research Reports
|
March 23, 2026
First-Line Cemiplimab for Locally Advanced NSCLC: Updated Subgroup Analyses From the EMPOWER-Lung 1 and EMPOWER-Lung 3 Trials
Ewa Kalinka, Igor Bondarenko, Miranda Gogishvili, et al.
Cancer
|
May 5, 2025
Cemiplimab monotherapy as first-line treatment of patients with brain metastases from advanced non-small cell lung cancer with programmed cell death-ligand 1 ≥50
Saadettin Kilickap, Mustafa Özgüroğlu, Ahmet Sezer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 15, 2026
Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-year Results From Phase 3 EMPOWER-Lung 3 Part 2 Trial
Ana Baramidze, Tamta Makharadze, Miranda Gogishvili, et al.
Cancer Treatment and Research Communications
|
July 23, 2025
Peripheral blood cells as prognostic markers in patients with advanced non-small cell lung cancer treated with cemiplimab as monotherapy or in combination with chemotherapy
Rolando J Acosta, Debra A G McIntyre, Joseph C Murray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 20, 2024
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, et al.
Page
of 2